Projects:PathologyAnalysis

From NAMIC Wiki
Jump to: navigation, search
Home < Projects:PathologyAnalysis

Back to Utah 2 Algorithms


Analysis of Brain Images with Variety of Cerebral Lesion Types

Description

Traumatic brain injury (TBI) occurs when an external force traumatically injures the brain. TBI is a major cause of death and disability worldwide, especially in children and young adults. TBI affects 1.4 million Americans annually. The UCLA medical school has been working on this topic for years.

On anatomical MRI scans, to quantitatively analyze the cortical thickness, white matter changes, we need to have a good segmentation on TBI images. However, for TBI data, standard automated image analysis methods are not robust with respect to the TBI-related changes in image contrast, changes in brain shape, cranial fractures, white matter fiber alterations, and other signatures of head injury.

We are working on an extension of the "atlas-based classification" method ABC [1] for TBI datasets with the clinical goal to efficiently segment healthy brain tissue and cerebral lesions. A main goal will be the automated segmentation of healthy brain tissue and user-assisted segmentation of various cerebral lesion types (hematoma, subarachnoid hemorrhage, contusion and DAI, perifocal (regional) to diffuse (generalized) edema, hemorrhagic diffuse axonal injury (DAI)and more. A strong emphasis will be on the joint of multiple imaging modalities (T1 pre- and T1 postcontrast, T2 (TSE), FLAIR, GRE, SWI, Perfusion, and DTI/DWI) for improved detection and quantitative characterization of lesion types.

Multimodal MRI data of TBI patient.

Experiments: Multi-modal registration and tissue segmentation

We conducted experiments with the application of the ABC tool to multi-modal image data of 5 TBI cases provided by DBP partner UCLA. The tool includes co-registration of multiple modalities via mutual-information linear registration, and a nonlinear registration (high-deformable fluid registration) of a probabilistic normative atlas for segmentation of healthy tissue. The following results show feasibility of multi-modal registration and segmentation of normal tissue. Pathology is currently segmented via postprocessing using 3D user-supervised level-set evolution.

Case 1: Segmentation of 5channel TBI data with ABC. Lesions and ventricles segmented with additional 3D level-set segmentation.
Case 2: Segmentation of 5channel TBI data with ABC. Lesions and ventricles segmented with additional 3D level-set segmentation.
Case 3: Segmentation of 5channel TBI data with ABC. Lesions and ventricles segmented with additional 3D level-set segmentation.

Current work, jointly with the UCLA DBP partner, centers about a clinical definition of the most common lesion types and a multi-modality MRI characterization definition of these patterns. These characterizations will be used for the development of a segmentation methodology of the broad range of cerebral lesion types based on a user-guided definition of such patterns in current TBI cases.

Experiments: Registration of longitudinal data

The NA-MIC DBP project on TBI analysis (UCLA partner) includes serial multi-modal MRI at acute phase and follow-up after six months. We test mutual-information-based linear registration of multi-modal MRI data within each time point and nonlinear registration (b-spline) of follow-up scans to obtain sets of images mapped into the same coordinate system. Preliminary results demonstrate the large deformations due to mass effect of a large lesion but also significant large regional changes of multi-modal MRI contrast from actute to follow-up.


Longitudinal co-registration of multi-modal MRI.
Segmented white matter and temporal lobe (yellow) at acute phase and after 6 month follow-up.


Conclusion

In this work, we develop a new methodology for user-guided segmentation of cerebral lesions in multi-modal brain MRI.

Literature

[1]

Key Investigators

  • Utah: Bo Wang, Marcel Prastawa, Guido Gerig
  • UCLA: Jack Van Horn, Andrei Irimia, Micah Chambers / Clinical partners: Paul Vespa, M.D., David Hovda, M.D.

References